ReviewFuture oncology (London, England)2025
Tislelizumab for the treatment of advanced esophageal squamous cell carcinoma.
Kazuhiro Shiraishi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewFuture oncology (London, England)2025
Kazuhiro Shiraishi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.